GlassVC

Pfizer Ventures

Venture capital firm · Founded 2004 · New York, NY, United States · New York ↗

Pfizer Ventures is the corporate venture capital arm of Pfizer, investing in companies developing innovative therapeutics and platform technologies in areas including oncology, inflammation and immunology, cardiovascular and metabolic diseases and vaccines, from seed through IPO with an emphasis on early-stage opportunities.

Tier 1Basis: Grouped by disclosed AUM of $1.3B (AUM-band grouping — full tier basis pending in the catalog).

Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

This profile is unclaimed. Built from public sources. If you're a partner or employee at Pfizer Ventures, you can claim it.

Claim this profileHow claiming works

Key numbers

Assets under management

$1.3B

Latest fund

Not publicly disclosed

LAST CHECKED NOV 2026

Funds

No public record

LAST CHECKED NOV 2026

Check size

$5M–$20M

Stages

SeedSeries ASeries B

Sectors

OncologyInflammation & ImmunologyCardiovascularMetabolic/ObesityVaccines

FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG

Track record

Outcomes are recorded from public sources and attributed to the firm, not to individual partners. Shutdowns and write-offs are an ordinary part of venture investing; inclusion here is a record, not a judgment.

Hits

  • Morphic Therapeutics

    Acquired by Eli Lilly ($3.2B, 2024) — BioSpace's profile of Pfizer Ventures notes portfolio company Morphic Therapeutics was acquired by Eli Lilly for $3.2 billion in 2024.

    Source: biospace.com

Misses

  • Ribon TherapeuticsShut down (2024)

    BioSpace's profile of Pfizer Ventures notes portfolio company Ribon Therapeutics closed down in 2024.

    Source: biospace.com

  • MetabomedShut down (2024)

    BioSpace's profile of Pfizer Ventures notes portfolio company Metabomed closed down in 2024.

    Source: biospace.com

Partners 4

Reputation 3

No reputation score — basis not established for this firm.

Contact

Published sources only

Published contact

No contact details published by this firm.

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Suggest a source

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Pfizer Ventures. Reviews come from founders whose identity and relationship have been verified.

Write the first review

Methodology

Tier basis — Grouped by disclosed AUM of $1.3B (AUM-band grouping — full tier basis pending in the catalog). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.

The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Pfizer Ventures — provenance: GlassVC catalog census, November 2026

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Track record · Reputation

PROFILE BUILT FROM PUBLIC SOURCES · 1 CATALOG SOURCE · LAST CHECKED NOV 2026